ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 890

$906K Total Retail Price of All Prescriptions

Rank: 67 out of 890

456 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

10% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,575 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 595 457 1 5
LEVOTHYROXINE SODIUM 549 523 2 2
OMEPRAZOLE 465 377 3 8
AMLODIPINE BESYLATE 410 289 4 1
METFORMIN HCL 343 256 5 6
ENALAPRIL MALEATE 318 243 6 56
NAMENDA 313 313 7 36
FUROSEMIDE 287 208 8 7
MELOXICAM 266 243 9 18
HYDROCHLOROTHIAZIDE 218 158 10 9
DONEPEZIL HCL 213 213 11 30
WARFARIN SODIUM 203 166 12 24
CARVEDILOL 203 183 12 22
CITALOPRAM HBR 201 180 14 20
LISINOPRIL 197 154 15 4
METOPROLOL SUCCINATE 187 132 16 17
GABAPENTIN 185 140 17 12
HYDROCODONE-ACETAMINOPHEN 176 111 S3 18 3
ATORVASTATIN CALCIUM 173 140 19 13
ZOLPIDEM TARTRATE 171 146 20 19
PRAVASTATIN SODIUM 170 144 21 10
NEXIUM 166 130 22 14
TRAMADOL HCL-ACETAMINOPHEN 154 133 23 117
METOPROLOL TARTRATE 152 122 24 15
ESCITALOPRAM OXALATE 150 129 25 51
LOSARTAN POTASSIUM 148 138 26 29
QUETIAPINE FUMARATE 145 138 27 73
EXELON 141 141 28 113
TRAMADOL HCL 134 94 29 16
CRESTOR 125 79 30 25
TAMSULOSIN HCL 123 103 31 32
LOSARTAN-HYDROCHLOROTHIAZIDE 123 87 31 57
CLOPIDOGREL 121 102 33 28
POTASSIUM CHLORIDE 118 102 34 11
TRAZODONE HCL 110 72 35 40
GLIMEPIRIDE 104 76 36 27
CYMBALTA 103 74 37 45
ENALAPRIL-HYDROCHLOROTHIAZIDE 101 60 38 230
ALLOPURINOL 99 59 39 31
POLYETHYLENE GLYCOL 3350 95 91 40 67
DOXYCYCLINE HYCLATE 93 66 41 89
FENOFIBRATE 93 31 41 74
GLIPIZIDE ER 92 92 43 110
ACTOS 90 72 44 88
FLUTICASONE PROPIONATE 88 68 45 39
KLOR-CON M20 86 86 46 72
GLYBURIDE-METFORMIN HCL 84 74 R 47 115
SERTRALINE HCL 83 71 48 26
BUMETANIDE 81 60 49 134
CIPROFLOXACIN HCL 79 73 50 58
NAPROXEN 78 54 51 84
PLAVIX 77 58 52 42
ADVAIR DISKUS 76 56 53 52
LANTUS 75 55 54 50
CYCLOBENZAPRINE HCL 73 42 R 55 64
FAMOTIDINE 72 48 56 90
LIDODERM 71 57 57 227
CLONIDINE HCL 70 44 58 35
LIPITOR 68 54 59 77
DIOVAN HCT 65 57 60 48
SEROQUEL 65 58 60 167
AMITRIPTYLINE HCL 65 52 R 60 43
RISPERIDONE 63 60 63 78
MECLIZINE HCL 61 60 64 97
DIOVAN 61 53 64 33
ISOSORBIDE MONONITRATE ER 60 49 66 60
PREDNISONE 59 58 67 47
SINGULAIR 58 49 68 79
AMLODIPINE BESYLATE-BENAZEPRIL 58 57 68 41
TRIAMTERENE-HCTZ 58 58 68 61
WELCHOL 57 57 71 226
CLOTRIMAZOLE-BETAMETHASONE 55 46 72 152
VERAPAMIL ER 55 43 72 87
EVISTA 55 43 72 182
RANITIDINE HCL 54 42 75 49
JANUVIA 54 32 75 59
LEXAPRO 54 46 75 186
MUPIROCIN 54 36 75 121
PREMARIN 53 41 R 79 105
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 46 80 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.